Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Reorganizes Into Three Business Units
Pharmalot
Tuesday, October 7, 2008 - 10:19am
tags:
Four Value Priced Stocks: Sysco, Eli Lilly, PepsiCo and Johnson & Johnson
Seeking Alpha
Tuesday, October 7, 2008 - 10:06am
tags:
Cypress Bioscience, Worth Watching for Fibromyalgia Drug
Cafepharma Detailpiece
Tuesday, October 7, 2008 - 10:05am
tags:
NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies
Yahoo
Tuesday, October 7, 2008 - 9:04am
tags:
Biotech ETFs Hold Their Own During Crisis
Seeking Alpha
Tuesday, October 7, 2008 - 8:47am
tags:
Drugmakers Urged By UK To Lower Prices
Pharmalot
Tuesday, October 7, 2008 - 8:47am
tags:
Shire colitis drug 'demonstrates steady medicine release'
Hays Pharma
Tuesday, October 7, 2008 - 8:46am
tags:
Salix Pharmaceuticals (SLXP) Presents Data on Mesalamine Granules Once-Daily Maintained Remission at ACG 2008
Street Insider
Tuesday, October 7, 2008 - 8:40am
tags:
Eli Lilly resolves investigation over Zyprexa with 32 states
Marketwatch
Tuesday, October 7, 2008 - 8:39am
tags:
AtheroGenics Files for Chapter 11 Bankruptcy
Yahoo
Tuesday, October 7, 2008 - 8:22am
tags:
Alpharma agrees to share confidential financials with suitor King Pharmaceuticals
Yahoo/AP
Tuesday, October 7, 2008 - 8:21am
tags:
Medicine for a sector
FT.com
Tuesday, October 7, 2008 - 7:53am
tags:
Medtronic CEO Hawkins Says Stent Patent Win Worth $114 Million
Bloomberg
Tuesday, October 7, 2008 - 7:52am
tags:
UBS Helps Lilly Buy ImClone, Says Price Too High
Bloomberg
Tuesday, October 7, 2008 - 7:50am
tags:
Genentech and Biogen say Rituxan slowed leukemia progress in late stage clinical trial
Yahoo/AP
Tuesday, October 7, 2008 - 7:49am
tags:
Four Thoughts on the Imclone/Lilly Deal
Seeking Alpha
Tuesday, October 7, 2008 - 7:46am
tags:
A Biotech Bonanza for ImClone and Dendreon
Seeking Alpha
Tuesday, October 7, 2008 - 7:45am
tags:
Synavive data sends CombinatoRx to all-time lows
Yahoo/AP
Tuesday, October 7, 2008 - 7:44am
tags:
Fitch may downgrade Eli Lilly's 'AA' on ImClone buy
Marketwatch
Tuesday, October 7, 2008 - 7:43am
tags:
Dendreon Misses, Moves Up
Forbes
Monday, October 6, 2008 - 10:58am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.